Diazepam Syri Pharma 0
As listed in the register: Diazepam Syri Pharma 0,4 mg/ml, suspensie voor oraal gebruik
0,4 mg/ml · suspensie voor oraal gebruik
- Prescription only
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Diazepam
- Made by
- Syri Pharma Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Diazepam). It describes the substance, not this exact product.
Diazepam is a benzodiazepine that exerts anxiolytic, sedative, muscle-relaxant, anticonvulsant and amnestic effects.
Most of these effects are thought to result from a facilitation of the action of gamma aminobutyric acid (GABA), an inhibitory neurotransmitter in the central nervous system.
N-desmethyldiazepam and temazepam are both further metabolized to oxazepam.
Diazepam and its metabolites are excreted mainly in the urine, predominantly as their glucuronide conjugates.
Absorption is delayed and decreased when administered with a moderate fat meal.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-08-27
Safety of the active substance
From the US prescribing label for the same active substance (Diazepam). It describes the substance, not this exact product.
WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS.
- Diazepam tablets are contraindicated in patients with a known hypersensitivity to diazepam and, because of lack of sufficient clinical experience, in pediatric patients under 6 months of age.
- Diazepam tablets are also contraindicated in patients with myasthenia gravis, severe respiratory insufficiency, severe hepatic insufficiency, and sleep apnea syndrome.
- They may be used in patients with open-angle glaucoma who are receiving appropriate therapy, but is contraindicated in acute narrow-angle glaucoma.
Most commonly reported were drowsiness, fatigue, muscle weakness, and ataxia.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Syri Pharma Limited |
|---|---|
| Active substance | Diazepam |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 0,4 mg/ml |
| Form | suspensie voor oraal gebruik |
| Classification | N05BA01 · Pain, sleep, mood, epilepsy and the brain |
| Route | oraal gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| Name in the register | Diazepam Syri Pharma 0,4 mg/ml, suspensie voor oraal gebruik |
| RVG | 132835 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.